AcneFree Purchase Builds U.S. Scale For Canadian Dermatology Firm
This article was originally published in The Rose Sheet
Executive Summary
The addition of AcneFree to Valeant Pharma’s OTC portfolio will complement the Montreal firm’s CeraVe skin hydration line and augment its shelf space in U.S. retail doors. Valeant announced $64 million purchase from University Medical earlier this month.
You may also be interested in...
Valeant Builds Outside Of Dermatology With Bausch + Lomb Buy
Acquisition of Bausch + Lomb for $8.7 billion vaults Valeant Pharmaceuticals into consumer eye care and positions the firm to compete against pharma giants. Analysts see the move as representing “a good fit,” and the acquisition is not likely to be the last for Valeant, which has made M&A an integral part of its strategy.
With Vicept Buy, Allergan Gains Rosacea Treatment Under Development
Drug firm Allergan Inc. has a daily rosacea treatment in the development pipeline following its acquisition of privately held specialty biopharmaceutical firm Vicept Therapeutics in July.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.